bpc-157 approval status fda advisory committee votes to add popular peptide to drug compounding list Important Update on FDA Changes
Important Update on FDA Changes Concerning Peptides UNDER SCRUTINY: Seven peptides go before advisory committee this week for uses ranging from weight loss and wound healing to opioid withdrawal. The compounds including BPC 157, MOTS c and Semax could This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the FDA will make 3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for 83% of peptide aware Americans want the FDA to make peptides more accessible AOL
Pay in 4 interest-free payments of $5.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

